According to NanoString Technologies's latest financial reports the company has $97.1 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.19 B | -43.67% |
2021-12-31 | $0.34 B | -20.84% |
2020-12-31 | $0.44 B | 180.98% |
2019-12-31 | $0.15 B | 66.87% |
2018-12-31 | $93.99 M | 21.2% |
2017-12-31 | $77.55 M | 4.75% |
2016-12-31 | $74.03 M | 50.96% |
2015-12-31 | $49.04 M | -32.1% |
2014-12-31 | $72.22 M | 69.32% |
2013-12-31 | $42.65 M | 96.64% |
2012-12-31 | $21.69 M | 99.6% |
2011-12-31 | $10.86 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $8.07 B | 8,218.14% | ๐บ๐ธ USA |
Agilent Technologies A | $1.74 B | 1,700.19% | ๐บ๐ธ USA |
Illumina ILMN | $1.05 B | 985.47% | ๐บ๐ธ USA |
PerkinElmer
PKI | $2.46 B | 2,434.63% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | $0.63 B | 550.27% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $1.60 B | 1,555.12% | ๐บ๐ธ USA |